These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 15231079)

  • 1. Seroprevalence of Kaposi's sarcoma-associated herpesvirus in various populations in Cuba.
    Kourí V; Eng SM; Rodríguez ME; Resik S; Orraca O; Moore PS; Chang Y
    Rev Panam Salud Publica; 2004 May; 15(5):320-5. PubMed ID: 15231079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen.
    Simpson GR; Schulz TF; Whitby D; Cook PM; Boshoff C; Rainbow L; Howard MR; Gao SJ; Bohenzky RA; Simmonds P; Lee C; de Ruiter A; Hatzakis A; Tedder RS; Weller IV; Weiss RA; Moore PS
    Lancet; 1996 Oct; 348(9035):1133-8. PubMed ID: 8888167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroreactivity to Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent nuclear antigen in AIDS-associated Kaposi's sarcoma patients depends on CD4+ T-cell count.
    de Souza VA; Pierrotti LC; Sumita LM; Freire WS; Segurado AA; Pannuti CS
    J Med Virol; 2007 Oct; 79(10):1562-8. PubMed ID: 17705173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 in several regions of Italy.
    Calabrò ML; Sheldon J; Favero A; Simpson GR; Fiore JR; Gomes E; Angarano G; Chieco-Bianchi L; Schulz TF
    J Hum Virol; 1998; 1(3):207-13. PubMed ID: 10195244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal sero-reactivity to human herpesvirus 8 (KSHV) in the Swiss HIV Cohort 4.7 years before KS.
    Quinlivan EB; Wang RX; Stewart PW; Kolmoltri C; Regamey N; Erb P; Vernazza PL;
    J Med Virol; 2001 Jun; 64(2):157-66. PubMed ID: 11360248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for Kaposi's-sarcoma-associated herpesvirus (KSHV/HHV-8) seropositivity in a cohort of homosexual men, 1981-1996.
    Melbye M; Cook PM; Hjalgrim H; Begtrup K; Simpson GR; Biggar RJ; Ebbesen P; Schulz TF
    Int J Cancer; 1998 Aug; 77(4):543-8. PubMed ID: 9679756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and transmission of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in Ugandan children and adolescents.
    Mayama S; Cuevas LE; Sheldon J; Omar OH; Smith DH; Okong P; Silvel B; Hart CA; Schulz TF
    Int J Cancer; 1998 Sep; 77(6):817-20. PubMed ID: 9714046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing Kaposi's sarcoma-associated herpesvirus seroprevalence with age in a highly Kaposi's sarcoma endemic region, Zambia in 1985.
    Olsen SJ; Chang Y; Moore PS; Biggar RJ; Melbye M
    AIDS; 1998 Oct; 12(14):1921-5. PubMed ID: 9792393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kaposi's sarcoma-associated herpesvirus seroprevalence in selected german patients: evaluation by different test systems.
    Preiser W; Szép NI; Lang D; Doerr HW; Rabenau HF
    Med Microbiol Immunol; 2001 Dec; 190(3):121-7. PubMed ID: 11827200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sexual transmission and the natural history of human herpesvirus 8 infection.
    Martin JN; Ganem DE; Osmond DH; Page-Shafer KA; Macrae D; Kedes DH
    N Engl J Med; 1998 Apr; 338(14):948-54. PubMed ID: 9521982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of Kaposi's sarcoma-associated herpes virus transmission from donor allografts among Italian posttransplant Kaposi's sarcoma patients.
    Parravicini C; Olsen SJ; Capra M; Poli F; Sirchia G; Gao SJ; Berti E; Nocera A; Rossi E; Bestetti G; Pizzuto M; Galli M; Moroni M; Moore PS; Corbellino M
    Blood; 1997 Oct; 90(7):2826-9. PubMed ID: 9326251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infection with Kaposi's sarcoma-associated herpesvirus among families of patients with classic Kaposi's sarcoma.
    Guttman-Yassky E; Kra-Oz Z; Dubnov J; Friedman-Birnbaum R; Segal I; Zaltzman N; Roth T; Schwartz F; Linn S; Rozenman D; David M; Silbermann M; Barchana M; Bergman R; Sarid R
    Arch Dermatol; 2005 Nov; 141(11):1429-34. PubMed ID: 16301390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal analysis of the humoral response to Kaposi's sarcoma-associated herpesvirus after primary infection in children.
    Olp LN; Minhas V; Gondwe C; Poppe LK; Rogers AM; Kankasa C; West JT; Wood C
    J Med Virol; 2016 Nov; 88(11):1973-81. PubMed ID: 27062052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence of Kaposi's sarcoma-associated herpesvirus among men who have sex with men in Japan.
    Katano H; Yokomaku Y; Fukumoto H; Kanno T; Nakayama T; Shingae A; Sugiura W; Ichikawa S; Yasuoka A
    J Med Virol; 2013 Jun; 85(6):1046-52. PubMed ID: 23588730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence of Kaposi's sarcoma-associated herpesvirus and risk factors in Xinjiang, China.
    Fu B; Sun F; Li B; Yang L; Zeng Y; Sun X; Xu F; Rayner S; Guadalupe M; Gao SJ; Wang L
    J Med Virol; 2009 Aug; 81(8):1422-31. PubMed ID: 19551832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of human sera reactivities in immunoblots with recombinant human herpesvirus (HHV)-8 proteins associated with the latent (ORF73) and lytic (ORFs 65, K8.1A, and K8.1B) replicative cycles and in immunofluorescence assays with HHV-8-infected BCBL-1 cells.
    Zhu L; Wang R; Sweat A; Goldstein E; Horvat R; Chandran B
    Virology; 1999 Apr; 256(2):381-92. PubMed ID: 10191203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of infection with human herpesvirus 8/Kaposi's sarcoma herpesvirus in rural South Africa.
    Wilkinson D; Sheldon J; Gilks CF; Schulz TF
    S Afr Med J; 1999 May; 89(5):554-7. PubMed ID: 10416461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of Kaposi's sarcoma-associated herpesvirus in HIV-1-infected US persons in the era of combination antiretroviral therapy.
    Labo N; Miley W; Benson CA; Campbell TB; Whitby D
    AIDS; 2015 Jun; 29(10):1217-25. PubMed ID: 26035321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification, expression, and immunogenicity of Kaposi's sarcoma-associated herpesvirus-encoded small viral capsid antigen.
    Lin SF; Sun R; Heston L; Gradoville L; Shedd D; Haglund K; Rigsby M; Miller G
    J Virol; 1997 Apr; 71(4):3069-76. PubMed ID: 9060668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma.
    Gao SJ; Kingsley L; Li M; Zheng W; Parravicini C; Ziegler J; Newton R; Rinaldo CR; Saah A; Phair J; Detels R; Chang Y; Moore PS
    Nat Med; 1996 Aug; 2(8):925-8. PubMed ID: 8705864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.